PASKALIUM
LOE Approachingpotassium aminosalicylate
NDAORALTABLET
Approved
Nov 1955
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PASKALIUM (potassium aminosalicylate) is an oral tablet formulation of a small-molecule antimicrobial agent used to treat tuberculosis, particularly drug-resistant forms. The drug works by inhibiting bacterial cell wall synthesis in Mycobacterium tuberculosis. It has been a foundational TB therapy since its approval in 1955.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30), the brand team is likely managing decline rather than growth, suggesting smaller teams and defensive positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PASKALIUM offers limited career growth due to its LOE-approaching lifecycle and zero linked job openings, but may suit professionals seeking to deepen expertise in global TB treatment access, emerging markets, or supply chain continuity. This role is more defensive and operational than strategic, requiring skills in managing declining portfolios and generic transitions rather than commercial expansion.
Product Manager (Specialty)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.